AlphaFold Meets De Novo Drug Design: Leveraging Structural Protein Information in Multitarget Molecular Generative Models
Open Access
- 30 October 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (21) , 8113-8122
Abstract
Recent advancements in deep learning and generative models have significantly expanded the applications of virtual screening for drug-like compounds. Here, we introduce a multitarget transformer model, PCMol, that leverages the latent protein embeddings derived from AlphaFold2 as a means of conditioning a de novo generative model on different targets. Incorporating rich protein representations allows the model to capture their structural relationships, enabling the chemical space interpolation of active compounds and target-side generalization to new proteins based on embedding similarities. In this work, we benchmark against other existing target-conditioned transformer models to illustrate the validity of using AlphaFold protein representations over raw amino acid sequences. We show that low-dimensional projections of these protein embeddings cluster appropriately based on target families and that model performance declines when these representations are intentionally corrupted. We also show that the PCMol model generates diverse, potentially active molecules for a wide array of proteins, including those with sparse ligand bioactivity data. The generated compounds display higher similarity known active ligands of held-out targets and have comparable molecular docking scores while maintaining novelty. Additionally, we demonstrate the important role of data augmentation in bolstering the performance of generative models in low-data regimes. Software package and AlphaFold protein embeddings are freely available at https://github.com/CDDLeiden/PCMol.Keywords
All Related Versions
Funding Information
- Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy (LM2023052)
- Grantov? Agentura Cesk? Republiky (22-17367O)
- Horizon 2020 Framework Programme (956832)
This publication has 44 references indexed in Scilit:
- DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representationComputers in Biology and Medicine, 2024
- The impact of AlphaFold Protein Structure Database on the fields of life sciencesProteomics, 2022
- Prediction reliability of QSAR models: an overview of various validation toolsArchives of Toxicology, 2022
- Embeddings from protein language models predict conservation and variant effectsHuman Genetics, 2021
- Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A reviewEuropean Journal of Medicinal Chemistry, 2021
- De novo molecular design and generative modelsDrug Discovery Today, 2021
- De Novo Molecule Design Through the Molecular Generative Model Conditioned by 3D Information of Protein Binding SitesJournal of Chemical Information and Modeling, 2021
- REINVENT 2.0: An AI Tool for De Novo Drug DesignJournal of Chemical Information and Modeling, 2020
- Machine learning models for drug–target interactions: current knowledge and future directionsDrug Discovery Today, 2020
- Multiple Sequence Alignment Using ClustalW and ClustalXCurrent Protocols in Bioinformatics, 2002